Thrombosis
From the Journals
Atrial fib guidelines may fall short on oral anticoagulation
Oral anticoagulation threshold according to CHA2DS2-VASc score varied widely after accounting for varying stroke rates in published studies.
Conference Coverage
Drug-coated stent bests bare metal in patients with high bleeding risk
SAN DIEGO – Positive
Conference Coverage
IMPERIAL: Eluvia stent tops Zilver PTX for PAD
SAN DIEGO – Uptake may be a matter of price.
Conference Coverage
Rivaroxaban bonus: Early unmasking of occult GI cancers
MUNICH – Secondary analysis of COMPASS trial hits pay dirt.
From the Journals
Expert panel updates guidelines on antithrombotic therapy for AF
The new guidelines highlight 60 key recommendations from the 12-person expert panel.
Conference Coverage
Think DEB, not BMS, with high bleeding risk
PARIS – Potentially practice-changing results of DEBUT trial.
Guidelines
New stroke intervention guidelines stress volume
From the Journals
Rivaroxaban superior to aspirin for extended VTE treatment
Researchers said there is no longer a place for aspirin in extended VTE treatment.
Conference Coverage
VTE risk unchanged by rivaroxaban after discharge
The MARINER study looked at postdischarge rivaroxaban in individuals who had been recently hospitalized and were at an increased risk of venous...
Cardiocast
Blood pressure control prevents cognitive impairment
Plus, does omega-3 supplementation do any good for the heart?
From the Journals
Guideline: PFO closure best bet for recurrent stroke prevention
Although a “weak” recommendation, PFO closure is named as the preferred therapy for reducing risk of recurrent stroke.